Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

On-time performance across the entire San Diego trolley system has been boosted by a year-old East County service change that inconveniences a relatively small number of riders. The number of late ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

"A Christmas Carol" continues to thrive across New England — on the page, on stage and even aboard a moving trolley.In Salem, Erik Rodenhiser and Mark Scalia bring the timeless tale to life as Jacob ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

New research shows how easily our imagined choices collapse under the weight of real consequences. Here’s why overthinking them never helps. For decades, the “trolley problem” has encouraged us to ...

Leave it to Elon Musk’s Grok to innovate new ways of being both staggeringly antisemitic and grovelingly deferential to its creator. In a series of posts on X, the AI chatbot was recently asked to ...

OMAHA, Neb. (WOWT) - Mayor John Ewing Jr. rode a trolley along the city’s streetcar construction route Sunday to promote businesses affected by the ongoing work. The mayor traveled on Ollie the ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...